Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
inHEART has developed an advanced AI-driven digital twin technology that transforms CT/MR images into highly detailed, interactive, patient-specific virtual models of the heart. This enables precise diagnosis, procedural planning, and execution for complex cardiac interventions such as ventricular tachycardia ablation. The company’s solutions are FDA-cleared and commercially available. Clinical use has demonstrated improved accuracy in identifying arrhythmogenic areas to optimize treatment strategies for challenging cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on inHEART.